Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
CTI Medtech Award Nomination for Automated, Quality Controlled Cell Culturing System
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
A novel automated solution developed through a collaboration between Tecan and researchers at the Zurich University of Applied Sciences in Wadenswil and at the University of Zurich, has been nominated for an award by Innovation Promotion Agency CTI of the Swiss Confederation.
http://www.icbc.zhaw.ch
The new automated system controls all required steps of cell culture, including isolation, seeding, proliferation, harvesting and quality control of cell lines and primary cells, providing standardized and procedures for research into regenerative medicine.
Prof Ursula Graf-Hausner, group leader of the Cell Biology Division at the Zurich University of Applied Sciences, said: “We have worked closely with Tecan throughout this project and I believe we have made a significant breakthrough. For us, it is an enormous achievement to be nominated alongside Switzerland’s prestigious universities and federal institutes.”
Prof Norbert Boos, Head of Spinal Surgery at the Orthopedic University Hospital Balgrist, and Head of the Spine Research Group, Centre of Applied Biotechnology and Molecular Medicine, University of Zurich, said: “Automated cell culture systems are a prerequisite to bring tissue engineering from the bench to the bedside. We have achieved a major leap forward in making regenerative medicine a clinical reality.”
Roland Durner, Director Market & Application Management for BioPharma at Tecan, added: “We are delighted that we continue to be closely involved at the forefront of cutting-edge scientific research, and are very pleased to be nominated for this much sought after award.”
http://www.icbc.zhaw.ch
The new automated system controls all required steps of cell culture, including isolation, seeding, proliferation, harvesting and quality control of cell lines and primary cells, providing standardized and procedures for research into regenerative medicine.
Prof Ursula Graf-Hausner, group leader of the Cell Biology Division at the Zurich University of Applied Sciences, said: “We have worked closely with Tecan throughout this project and I believe we have made a significant breakthrough. For us, it is an enormous achievement to be nominated alongside Switzerland’s prestigious universities and federal institutes.”
Prof Norbert Boos, Head of Spinal Surgery at the Orthopedic University Hospital Balgrist, and Head of the Spine Research Group, Centre of Applied Biotechnology and Molecular Medicine, University of Zurich, said: “Automated cell culture systems are a prerequisite to bring tissue engineering from the bench to the bedside. We have achieved a major leap forward in making regenerative medicine a clinical reality.”
Roland Durner, Director Market & Application Management for BioPharma at Tecan, added: “We are delighted that we continue to be closely involved at the forefront of cutting-edge scientific research, and are very pleased to be nominated for this much sought after award.”
